Results 181 to 190 of about 16,704,778 (257)

Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study [PDF]

, 2012
Diego Bellavia, Patricia A. Pellikka, Angela Dispenzieri, Christopher G. Scott, Ghormallah B. Al-Zahrani, Martha Grogan, Francesco Pitrolo, Jae K. Oh, Fletcher A. Miller   +8 more
openalex   +1 more source

Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis. [PDF]

Pharmaceuticals (Basel)
Morgan GJ, Yung Z, Spencer BH, Sanchorawala V, Prokaeva T.   +4 more
europepmc   +1 more source

Heparin-resistance in AL amyloidosis: a case report. [PDF]

BMC Anesthesiol, 2023
van Ede ES, Hoeks MPA, Hofland J, Linssen VD, van Kuppevelt TH, Versteeg EM, Hafmans TG, Diepstra A, Kusters B, Vermorgen SMM.   +9 more
europepmc   +1 more source

Therapy of AL amyloidosis – work-up and treatment at our centre [PDF]

, 2012
Christoph Kimmich, Ute Hegenbart, Hartmut Goldschmidt, A. D. Ho, Stefan Schönland   +4 more
openalex   +1 more source

Immune Therapies in AL Amyloidosis-A Glimpse to the Future. [PDF]

Cancers (Basel)
Haran A, Vaxman I, Gatt ME, Lebel E.
europepmc   +1 more source

Heart transplantation in systemic (AL) amyloidosis: A retrospective study of eight French patients

, 2008
Aude Mignot, Shaïda Varnous, M Redonnet, Arnaud Jaccard, Éric Epailly, Emmanuelle Vermès, P. Boissonnat, I Gandjbakhch, D Herpin, Guy Touchard, Frank Bridoux   +10 more
openalex   +1 more source

Feasibility of a Biomarker-Based Screening for Pre-Symptomatic AL Amyloidosis in Patients With Intermediate/High-Risk MGUS. [PDF]

Am J Hematol
Mangiacavalli S, Milani P, Cartia CS, Varettoni M, Palumbo M, Basset M, Masoni V, Nuvolone M, Foli A, Ferretti VV, Merlini G, Arcaini L, Palladini G.   +12 more
europepmc   +1 more source

The role of the kidney in AL amyloidosis

Nephrology Dialysis Transplantation, 2019
Priya P Deshpande, Kenar D. Jhaveri
openaire   +3 more sources

Defying the odds: 30 years in AL amyloidosis research-recent barriers to clinical trial enrollment. [PDF]

Blood Adv
Sanchorawala V, Barroso B, Shelton A, Goetz E, Mendelson L, Joshi T, Burke N, Sloan JM, Staron A.   +8 more
europepmc   +1 more source

Therapeutic Outcome of Cyclic VAD (Vincristine, Doxorubicin and Dexamethasone) Therapy in Primary Systemic AL Amyloidosis Patients

, 2008
Ko‐ichi Tazawa, Masayuki Matsuda, Takuhiro Yoshida, Takahisa Gono, Nagaaki Katoh, Yasuhiro Shimojima, Wataru Ishii, Tomohisa Fushimi, Jun Koyama, Shu‐ichi Ikeda   +9 more
openalex   +2 more sources